Hospital Universitario y Politécnico La Fe — Biomedical Watch V2

Essais liés9clinical trials

VilleValencialocalisation

PaysSpainlocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06185764

Ouvrir le site du centre

Essais cliniques associés

9

Molécule	Indication / population	Phase	NCT	Titre	Statut
Zanidatamab	Cancer	Phase 3	NCT06282575	Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer	RECRUITING
VX-670	Myopathies	Phase 1/2	NCT06185764	Galileo — A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)	ACTIVE_NOT_RECRUITING
Givinostat	Myopathies	Phase 3	NCT05933057	ULYSSES — Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy	RECRUITING
SAT-3247	Myopathies	Phase 2	NCT07287189	BASECAMP — Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients	RECRUITING
Rimegepant 75mg daily dosing	Migraine	Phase 4	NCT05217927	Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens	COMPLETED
Rimegepant	Migraine	Phase 3	NCT05156398	Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects	RECRUITING
Botulinum toxin type A	Migraine	Phase 3	NCT06047457	E-BEOND — A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults	ACTIVE_NOT_RECRUITING
Botulinum toxin type A	Migraine	Phase 3	NCT06047444	C-BEOND — A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults	ACTIVE_NOT_RECRUITING
Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy	Cancer	À vérifier	NCT02403869	Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy	COMPLETED